Common Contracts

Licensing agreement for COYA 301

Licensing Agreement • August 23rd, 2023 • New York

• Contract Type
  Licensing Agreement
• Filed
  August 23rd, 2023
• Jurisdiction
  New York

Coya Therapeutics announced expansion of its exclusive worldwide rights for the development and commercialization of COYA 301, the Company’s low-dose IL-2 subcutaneous administration product candidate.